Article Text

PDF

Cross-sectional analyses of participation in cancer screening and use of hormone replacement therapy and medications in meat eaters and vegetarians: the EPIC-Oxford study
  1. Tammy Y N Tong,
  2. Paul N Appleby,
  3. Kathryn E Bradbury,
  4. Timothy J Key
  1. Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
  1. Correspondence to Dr Tammy Y N Tong; tammy.tong{at}ndph.ox.ac.uk

Abstract

Objectives To examine differences in health-related behaviours such as screening or testing for cancer, use of hormone replacement therapy (HRT) and use of other medications in different diet groups.

Design We studied 31 260 participants across four diet groups (18 155 meat eaters, 5012 fish eaters, 7179 vegetarians, 914 vegans) in the UK EPIC-Oxford cohort. Information was collected in 5-year (around 2000–2003) or 10-year (around 2007) follow-up questionnaires regarding participation in breast screening, cervical screening, prostate-specific antigen (PSA) testing, use of HRT and use of medications for the past 4 weeks. Using Poisson regression, we estimated the prevalence ratios (PR) for each behaviour across people of different diet groups, using meat eaters as the reference group.

Results Compared with meat eaters, vegetarian (PR: 0.94, 95% CI 0.89 to 0.98) and vegan (PR: 0.82, 95% CI 0.71 to 0.95) women reported lower participation in breast screening, and vegetarian men were less likely to report PSA testing (PR: 0.82, 95% CI 0.71 to 0.96). No differences were observed among women for cervical screening. In women, all non-meat-eating groups reported lower use of HRT compared with meat eaters (P heterogeneity <0.0001). Lower reported use of any medication was observed for participants in all non-meat-eating groups with no (P<0.0001) or one (P=0.0002) self-reported illness. No heterogeneity was observed across the diet groups for the reported use of specific medication for high blood pressure, high blood cholesterol, asthma, diabetes and thyroid disease.

Conclusions Differences in self-reported breast screening, PSA testing, HRT use and overall medication use were observed across the diet groups. Whether such differences contribute to differential long-term disease risks requires further study.

  • oncology

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/

Statistics from Altmetric.com

Footnotes

  • Contributors TYNT, PNA and TJK conceived and designed the research question. TYNT and PNA analysed the data. TYNT wrote the first draft of the manuscript, and PNA, KEB and TJK provided input on data analysis and interpretation of results. All authors revised the manuscript critically for important intellectual content, and read and approved the final manuscript.

  • Funding The work is supported by the UK Medical Research Council MR/M012190/1 and Cancer Research UK 570/A16491 and C9221/A19170. KEB is supported by the Girdlers’ New Zealand Health Research Council Fellowship.

  • Competing interests TJK is a member of The Vegan Society. The other authors had no conflicts of interest.

  • Ethics approval The study protocol was approved by a multicentre research ethics committee (Scotland A Research Ethics Committee).

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement The data access policy for EPIC-Oxford is available via the study website (http://www.epic-oxford.org/data-access-sharing-and-collaboration/).

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.